Inge Muylle

691 total citations
12 papers, 278 citations indexed

About

Inge Muylle is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Inge Muylle has authored 12 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Inge Muylle's work include Tuberculosis Research and Epidemiology (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Mycobacterium research and diagnosis (3 papers). Inge Muylle is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Mycobacterium research and diagnosis (3 papers). Inge Muylle collaborates with scholars based in Belgium, United Kingdom and Spain. Inge Muylle's co-authors include R Sergysels, Marie Bruyneel, Vincent Ninane, Nathan Clumeck, Stéphane De Wit, Charlotte Martin, Yves Van Laethem, M. C. Payen, Nicolás Dauby and Jonas Yserbyt and has published in prestigious journals such as Journal of Leukocyte Biology, Cancers and The Pediatric Infectious Disease Journal.

In The Last Decade

Inge Muylle

12 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Muylle Belgium 10 174 135 66 54 47 12 278
Khalid M Dousa United States 12 195 1.1× 189 1.4× 38 0.6× 41 0.8× 20 0.4× 33 311
Bryan McGee United States 5 245 1.4× 135 1.0× 70 1.1× 20 0.4× 10 0.2× 12 366
Sergo Vashakidze Georgia 11 351 2.0× 252 1.9× 167 2.5× 27 0.5× 64 1.4× 20 517
PETER R. DONALD South Africa 8 284 1.6× 199 1.5× 163 2.5× 20 0.4× 16 0.3× 8 376
Thomas Maitre France 8 187 1.1× 175 1.3× 20 0.3× 12 0.2× 44 0.9× 16 248
Jagdish Rawat India 10 143 0.8× 116 0.9× 56 0.8× 7 0.1× 116 2.5× 38 285
Kohji Hashiguchi Japan 9 97 0.6× 141 1.0× 18 0.3× 11 0.2× 33 0.7× 25 213
Masamichi Komiya Japan 10 37 0.2× 46 0.3× 38 0.6× 39 0.7× 28 0.6× 52 320
Krzysztof Mądry Poland 8 166 1.0× 54 0.4× 20 0.3× 48 0.9× 15 0.3× 32 328
Nino Bablishvili Georgia 13 307 1.8× 242 1.8× 100 1.5× 39 0.7× 7 0.1× 18 351

Countries citing papers authored by Inge Muylle

Since Specialization
Citations

This map shows the geographic impact of Inge Muylle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Muylle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Muylle more than expected).

Fields of papers citing papers by Inge Muylle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Muylle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Muylle. The network helps show where Inge Muylle may publish in the future.

Co-authorship network of co-authors of Inge Muylle

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Muylle. A scholar is included among the top collaborators of Inge Muylle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Muylle. Inge Muylle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Dirix, Violette, Laetitia Aerts, Nicolás Dauby, et al.. (2021). Differential expression of maturation and activation markers on NK cells in patients with active and latent tuberculosis. Journal of Leukocyte Biology. 111(5). 1031–1042. 10 indexed citations
3.
Bruyneel, Marie, et al.. (2019). Severe pulmonary infections complicating nivolumab treatment for lung cancer: a report of two cases. Acta Clinica Belgica. 75(4). 308–310. 41 indexed citations
4.
Muylle, Inge, et al.. (2018). Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases. The International Journal of Tuberculosis and Lung Disease. 22(1). 34–39. 14 indexed citations
5.
Bothamley, Graham, Alena Skrahina, Àngels Orcau, et al.. (2016). Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey. BMC Pregnancy and Childbirth. 16(1). 304–304. 15 indexed citations
6.
Muylle, Inge, et al.. (2016). Driver oncogenes in Sub-Saharan African patients with non-small cell lung cancer. PubMed. Volume 7. 149–152. 3 indexed citations
7.
Yserbyt, Jonas, Christophe Dooms, Dries Testelmans, et al.. (2016). The Feasibility of Tracheal Oxygen Supplementation during Flexible Bronchoscopy. Respiration. 92(1). 48–52. 10 indexed citations
8.
Günther, Gunar, Frank van Leth, Neus Altet, et al.. (2015). Beyond multidrug-resistant tuberculosis in Europe: a TBNET study. The International Journal of Tuberculosis and Lung Disease. 19(12). 1524–1527. 16 indexed citations
9.
Dooms, Christophe, et al.. (2013). Endobronchial ultrasound in the management of nonsmall cell lung cancer. European Respiratory Review. 22(128). 169–177. 12 indexed citations
10.
Paesmans, Marianne, et al.. (2013). Asthma control measurement using five different questionnaires: A prospective study. Respiratory Medicine. 107(9). 1314–1321. 23 indexed citations
11.
Payen, M. C., Stéphane De Wit, Charlotte Martin, et al.. (2012). Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis [Case study]. The International Journal of Tuberculosis and Lung Disease. 16(4). 558–560. 83 indexed citations
12.
Dauby, Nicolás, et al.. (2011). Meropenem/Clavulanate and Linezolid Treatment for Extensively Drug-resistant Tuberculosis. The Pediatric Infectious Disease Journal. 30(9). 812–813. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026